Xianju Pharmaceutical: Signed a tripartite agreement with the company Aishijian to promote the sodium gluconate injection within China.

Announcement from Xianju Pharmaceutical: The company, along with Hangzhou Omniscient Pharmaceutical Co., Ltd., jointly authorized Aishijian Pharmaceutical Co., Ltd. as the exclusive market promotion service provider for sodium aescinate injection in China. At the same time, the two parties also signed commercial milestone profit-sharing agreements and sales revenue profit-sharing agreements, with each party receiving 50% of the commercial profits. In addition, they also signed agreements for raw material procurement and supply, as well as a contract for entrusted processing and production supplement.